FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Acids patents



      
           
This page is updated frequently with new Acids-related patent applications. Subscribe to the Acids RSS feed to automatically get the update: related Acids RSS feeds. RSS updates for this page: Acids RSS RSS


Date/App# patent app List of recent Acids-related patents
08/14/14
20140230101
 Enzymes that synthesize zingiberene patent thumbnailEnzymes that synthesize zingiberene
The invention relates to nucleic acids encoding a zingiberene synthase that enables host cells and plants to make zingiberene that is useful in fragrances and for repelling or killing insects. The invention also relates to isolated zingiberene synthases and to methods for making zingiberenes..
08/14/14
20140230094
 Yield increase in plants overexpressing the shsrp genes patent thumbnailYield increase in plants overexpressing the shsrp genes
A transgenic crop plant transformed by a serine hydroxymethyltransferase-like stress-related polypeptide (shsrp) coding nucleic acid, wherein expression of the nucleic acid sequence in the crop plant results in the plant's increased root growth, and/or increased yield, and/or increased tolerance to environmental stress as compared to a wild type variety of the plant. Also provided are agricultural products, including seeds, produced by the transgenic crop plants.
08/14/14
20140230087
 Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants patent thumbnailRegulatory nucleic acid molecules for enhancing constitutive gene expression in plants
The present invention is in the field of plant molecular biology and provides methods for production of high expressing constitutive promoters and the production of plants with enhanced constitutive expression of nucleic acids wherein nucleic acid expression enhancing nucleic acids (neenas) are functionally linked to said promoters and/or introduced into plants.. .
08/14/14
20140228597
 Process for the manufacture of dihalodiphenylsulfones starting from organic acids patent thumbnailProcess for the manufacture of dihalodiphenylsulfones starting from organic acids
A process for the preparation of dihalodiphenylsulfones_such as 4,4′-dichlorodiphenyl sulfone or 4,4′-bis-(4-chlorophenylsulfonyl)biphenyl with high regioselectivity, at low temperature and in the absence of toxic reagents by reacting together at least one acid, sulfur trioxide and at least one halobenzene. The invented process is particularly suited for the manufacture of 4,4′-dichlorodiphenyl sulfone..
08/14/14
20140228546
 Serum albumin binding proteins patent thumbnailSerum albumin binding proteins
The present invention relates to amino acid sequences that are capable of binding to serum albumin; to proteins and polypeptides comprising or essentially consisting of such amino acid sequences; to nucleic acids that encode such amino acid sequences, proteins or polypeptides; to compositions, and in particular pharmaceutical compositions, that comprise such amino acid sequences, proteins and polypeptides; and to uses of such amino acid sequences, proteins and polypeptides.. .
08/14/14
20140228494
 Polyol ester plasticizers and process of making the same patent thumbnailPolyol ester plasticizers and process of making the same
Triglyceride and other polyol ester pvc plasticizers can be produced by recovery of branched c6 to c9 aldehydes from a hydroformylation product, optional hydrogenation to the alcohol, oxidation to the acid with oxygen and/or air, recovery of the resulting acid, and esterification with glycerol, ethylene glycol, propylene glycol or mixtures thereof. The branched alkyl chains comprise at least 10% methyl branching.
08/14/14
20140228456
 Novel demulsifiers patent thumbnailNovel demulsifiers
The invention relates to novel demulsifiers for use in the demulsification of oils from water and vice versa, including the demulsification of crude oil from sea water or brine. In particular, the present invention relates to novel demulsifiers which are environmentally friendly, or ‘green’, and which can be used without restriction on-site in offshore oil drilling fields, for example in the north sea.
08/14/14
20140228417
 Process and intermediates for the preparation of substituted 2-arylthiazole carboxylic acids patent thumbnailProcess and intermediates for the preparation of substituted 2-arylthiazole carboxylic acids
The present invention relates to processes and intermediates for the preparation of derivatives of 2-arylthiazole such as febuxostat and its analogs. Febuxostat which is an inhibitor of xanthine oxidase, is used for the treatment of chronic hyperuricaemia in conditions in which urate deposition has occurred, such as gouty arthritis..
08/14/14
20140228416
 Substituted hydroxamic acids and uses thereof patent thumbnailSubstituted hydroxamic acids and uses thereof
Wherein x1, x2, x3, r2, r4b, r1, and g have values as described in the specification, useful as inhibitors of hdac6. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative, inflammatory, infectious, neurological or cardiovascular diseases or disorders..
08/14/14
20140228374
 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof patent thumbnailHeterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
And the tautomers and the salts thereof, particularly the pharmaceutically acceptable salts thereof with inorganic or organic acids and bases, which have valuable pharmacological properties, particularly an inhibitory effect on epithelial sodium channels, and the use thereof for the treatment of diseases, particularly diseases of the lungs and airways.. .
08/14/14
20140228296
Diagnosis, prognosis, and treatment of kidney disease
The present invention relates to the discovery that an increased fraction of albumin is carbamylated in patients suffering from kidney disease (e.g., end-stage renal disease) and that the fraction of carbamylated albumin is also correlated with increased disease severity, particularly risk of mortality. The present invention also relates to the discovery that free amino acids can reduce carbamylation of albumin.
08/14/14
20140228247
Sequence-specific analysis of nucleic acids
The invention relates to a method for the sequence-specific analysis of nucleic acids in a sample in which the nucleic acid is present at least partially as a double strand, which method uses electrochemical detection methods (e.g. With [oso4(bipy)]).
08/14/14
20140228233
Circulating biomarkers for cancer
Biomarkers can be assessed for diagnostic, therapy-related or prognostic methods to identify phenotypes, such as a condition or disease, or the stage or progression of a disease, select candidate treatment regimens for diseases, conditions, disease stages, and stages of a condition, and to determine treatment efficacy. Circulating biomarkers from a bodily fluid can be used in profiling of physiological states or determining phenotypes.
08/14/14
20140227799
Method for measuring anti-wt1 antibody
Provided is an invention relating to a method for measuring an anti-wt1 antibody in a sample allowing measurement and evaluation of the anti-wt1 antibody with higher accuracy and to use of the method. The method for measuring an anti-wt1 antibody in a sample includes using a polypeptide having antigenicity to the anti-wt1 antibody selected from a polypeptide comprising the amino acid sequence of positions 294-449 in seq id no: 1, a partial polypeptide of the polypeptide, and a polypeptide including an amino acid sequence having deletion, substitution, or addition of one to several amino acids in the amino acid sequence constituting each of these polypeptides and/or a polypeptide having antigenicity to the anti-wt1 antibody selected from a polypeptide comprising the amino acid sequence of positions 181-324 in seq id no: 1, a partial polypeptide of the polypeptide, and a polypeptide including an amino acid sequence having deletion, substitution, or addition of one to several amino acids in the amino acid sequence constituting each of these polypeptides..
08/14/14
20140227756
Egvi endoglucanase and nucleic acids encoding the same
The present invention provides a novel endoglucanase nucleic acid sequence, designated egl6, and the corresponding egvi amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding egvi, recombinant egvi proteins and methods for producing the same..
08/14/14
20140227748
Method for the epa enrichment of microalgae of the monodus genus cultivated in mixotrophic mode
Novel strains of microalgae belonging to the monodus genus allow optimum production of polyunsaturated fatty acids, notably epa, in mixotrophic mode. A method for selecting and culturing such strains, using a discontinuous supply of light in the form of flashes is also described..
08/14/14
20140227743
Dna polymerases with increased 3'-mismatch discrimination
Disclosed are mutant dna polymerases having increased 3′-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods.
08/14/14
20140227724
Nucleic acid construct for use in screening for peptide antibody, and screening method using same
The present invention provides a novel tool for simply screening a candidate molecule for an antibody and a method for screening a candidate molecule for an antibody using the tool. A nucleic acid construct includes: (x) an encoding nucleic acid of an antibody candidate, obtained by inserting an encoding nucleic acid of any peptide into an encoding nucleic acid of an antibody; (y) an encoding nucleic acid of a peptide tag; and (z) an encoding nucleic acid of an aptamer that is bindable to the peptide tag are used.
08/14/14
20140227712
Rapid method for isolating extracellular nucleic acids
The present invention pertains to a method for isolating extracellular nucleic acids from a sample, wherein said sample is optionally stabilized, by binding the extracellular nucleic acids to a solid phase which carries anion exchange groups, comprising the following steps: binding the extracellular nucleic acids to the solid phase in a binding mixture having a first ph which allows binding the extracellular nucleic acids to the anion exchange groups of the solid phase; wherein the sample makes up at least 85% of the volume of the binding mixture; separating the solid phase with the bound extracellular nucleic acids; optionally washing the extracellular nucleic acids; optionally eluting extracellular nucleic acids from the solid phase. The method has the advantage that large sample volumes can be processed and that extracellular nucleic acids can be isolated rapidly with a high yield.
08/14/14
20140227709
Methods of detecting low copy nucleic acids
Methods are provided for detecting low copy nucleic acids of interest in a sample. In one method, a sample comprising a nucleic acid of interest is aliquotted into a plurality of reaction mixtures, at least two of which are single-copy reaction mixtures.
08/14/14
20140227700
Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders
The invention provides methods, nucleic acids and kits for detecting prostate cell proliferative disorders. The invention discloses genomic sequences the methylation patterns of which have utility for the improved detection of said disorder, thereby enabling the improved diagnosis and treatment of patients..
08/14/14
20140227691
Nucleic acid isolation methods
The present invention provides methods for selectively enriching a biological sample for short nucleic acids, such as fetal dna in a maternal sample or apoptic dna in a biological sample from a cancer patient and for subsequently analyzing the short nucleic acids for genotype, mutation, and/or aneuploidy.. .
08/14/14
20140227689
Novel methods for quantification of micrornas and small interfering rnas
The invention relates to ribonucleic acids, probes and methods for detection, quantification as well as monitoring the expression of mature micrornas and small interfering rnas (sirnas). The invention furthermore relates to methods for monitoring the expression of other non-coding rnas, mrna splice variants, as well as detecting and quantifying rna editing, allelic variants of single transcripts, mutations, deletions, or duplications of particular exons in transcripts, e.g., alterations associated with human disease such as cancer.
08/14/14
20140227688
Stabilisation and isolation of extracellular nucleic acids
The present invention provides methods, compositions and devices for stabilizing the extracellular nucleic acid population in a cell-containing biological sample using an apoptosis inhibitor, preferably a caspase inhibitor, a hypertonic agent and/or a compound according to formula (1) as defined in the claims.. .
08/14/14
20140227687
Stabilisation and isolation of extracellular nucleic acids
The present invention provides methods, compositions and devices for stabilizing the extracellular nucleic acid population in a cell-containing biological sample using an apoptosis inhibitor, preferably a caspase inhibitor, a hypertonic agent and/or a compound according to formula (1) as defined in the claims.. .
08/14/14
20140227680
Compositions, methods and kits to detect adenovirus nucleic acids
The disclosed invention is related to methods, compositions, kits and isolated nucleic acid sequences for targeting adenovirus nucleic acid. Compositions include amplification oligomers and/or detection probe oligomers.
08/14/14
20140227641
Silicon-containing antireflective coatings including non-polymeric silsesquioxanes
Embodiments include a silicon-containing antireflective material including a silicon-containing base polymer, a non-polymeric silsesquioxane material, and a photoacid generator. The silicon-containing base polymer may contain chromophore moieties, transparent moieties, and reactive sites on an siox background, where x ranges from approximately 1 to approximately 2.
08/14/14
20140227433
Lanio3 thin film-forming composition and method of forming lanio3 thin film using the same
A lanio3 thin film having extremely few voids is uniformly formed. Provided is a lanio3 thin film-forming composition for forming a lanio3 thin film.
08/14/14
20140227386
Palatability enhancers comprising free amino acids for use in pet foods
The present invention concerns a palatability-enhancing composition for pet food, wherein said composition comprises about 1 to 70% by weight of free amino acids, as well as uses thereof, especially for producing pet foods having enhanced palatability. Cat food is more specifically concerned by the present invention..
08/14/14
20140227322
Rabies virus like particle production in plants
A method of producing a virus like particle (vlp) in a plant is provided. The method comprises introducing a first nucleic acid into the plant, or portion of the plant.
08/14/14
20140227319
Selecting, producing, and feeding whole algae as a feed supplement for cattle and bison to produce meat high in omega 3's for human health
The present invention is a system and method for creating and using algae as a food supplement for cattle and buffalo thereby providing a desirable food supplement for cattle and buffalo wherein the meat and fat produced has increased specific omega-3 polyunsaturated fatty acids for a product, which imparts a healthier cardiovascular or healthier central nervous system.. .
08/14/14
20140227270
Bispecific anti-cxcr7 immunoglobulin single variable domains
The present invention relates to particular polypeptides, nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to host cells expressing or capable of expressing such polypeptides; to compositions and in particular to pharmaceutical compositions that comprise such polypeptides, for prophylactic, therapeutic or diagnostic purposes. In particular, the present invention provides immunoglobulin single variable domains inhibiting cxcr7 mediated tumour growth..
08/14/14
20140227266
Nogo receptor antagonists
Disclosed are immunogenic nogo receptor-1 polypeptides, nogo receptor-1 antibodies, antigen-binding fragments thereof, soluble nogo receptors and fusion proteins thereof and nucleic acids encoding the same. Also disclosed are nogo receptor antagonist polynucleotides.
08/14/14
20140227261
Use of omega fatty acids for treating disease
Eicosapentaenoic acid (epa) and docosahexaenoic acid (dha), or a salt or an ester thereof, are provided for use in the treatment and/or prophylaxis of a condition selected from macular oedema, conditions causing damage to retinal photoreceptors and/or retinal pigment epithelial cells, and dry eyes in a mammal, wherein the combined dosage of eicosapentaenoic acid and docosahexaenoic acid is from 5 mmol to 25 mmol per day, and wherein the molar ratio of eicosapentaenoic acid to docosahexaenoic acid is in the range of from 1:1 to 5:1. Compositions comprising epa and dha and at least one pharmaceutically acceptable excipient, and kits containing epa, dha and further therapeutic agents are also provided.
08/14/14
20140227257
Monoclonal antibodies that neutralize anthrax protective antigen (pa) toxin
The present invention relates to monoclonal antibodies that bind or neutralize anthrax protective antigen (pa) toxin. The invention provides such antibodies, fragments of such antibodies retaining anthrax pa toxin-binding ability, fully human or humanized antibodies retaining anthrax pa toxin-binding ability, and pharmaceutical compositions including such antibodies.
08/14/14
20140227242
Compositions containing non-polar compounds
Provided are compositions and methods for producing stable foods and beverages that contain high concentrations of additives such as essential fatty acids, including omega-3 fatty acids, omega-6 fatty acids, conjugated fatty acids, and other fatty acids; phytochemicals, including phytosterols and carotenoids; oil soluble vitamins; alpha lipoic acid; other oils; and coenzymes, including coenzyme q10, and other oil-based additives.. .
08/14/14
20140227181
Method of labelling a biologically active molecule with 5-fluoro-5-deoxypentose or a 3-fluoro-3-deoxypentose
The invention provides a conjugate of a biologically active molecule and a 5-fluoro-5-deoxypentose or a 3-fluoro-3-deoxypentose, wherein the biologically active molecule is selected from the group consisting of proteins, peptides, nucleic acids, oligosaccharides and polysaccharides.. .
08/14/14
20140227146
System and method for processing biological samples
A system and method for processing and detecting nucleic acids from a set of biological samples, comprising: a molecular diagnostic module configured to receive nucleic acids bound to magnetic beads, isolate nucleic acids, and analyze nucleic acids, comprising a cartridge receiving module, a heating/cooling subsystem and a magnet configured to facilitate isolation of nucleic acids, a valve actuation subsystem including an actuation substrate, and a set of pins interacting with the actuation substrate, and a spring plate configured to bias at least one pin in a configurations, the valve actuation subsystem configured to control fluid flow through a microfluidic cartridge for processing nucleic acids, and an optical subsystem for analysis of nucleic acids; and a fluid handling system configured to deliver samples and reagents to components of the system to facilitate molecular diagnostic protocols.. .
08/14/14
20140225069
Organic electroluminescent materials and devices
Wherein r2 represents mono, di, tri, tetra, penta substitutions or no substitution; wherein r3, r4 and r5 each represent mono, di, tri, tetra substitutions or no substitution; wherein r9 represents mono, di, tri substitutions or no substitution; wherein r1 is selected from the group consisting of alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and r2, r3, r4 r5 and r9 are each independently selected from the group consisting of all options for r1, hydrogen, deuterium, halide, amino, silyl, and combinations thereof; and wherein n is 1 or 2. The device can include the compound according to formula i in an organic layer..
08/14/14
20140225021
Method for producing a dispersion and use of protein hydrolysates as dispersants
The present invention relates to a method for producing a dispersion and to the use of a protein hydrolysate as a dispersant or dispersing agent. In particular, the invention relates to a method for producing a suspension as well as the use of a protein hydrolysate as a dispersant in a suspension.


Popular terms: [SEARCH]



Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Acids for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Acids with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.2676

3140

1 - 1 - 71